The presence of IL-23 and IL-17 that characterizes HIV1+ individuals independent of their smoking status, as well as HIV1− smokers with low DLCO, suggests a potential role of Th17 cellular immune responses in the pathogenesis of emphysema in HIV1+ smokers. This evidence concerns the gene IL37 and pulmonary emphysema.